As part of the mammalian cell innate immune response, the doublestranded RNA activated protein kinase PKR phosphorylates the translation initiation factor eIF2␣ to inhibit protein synthesis and thus block viral replication. Poxviruses including vaccinia and smallpox viruses express PKR inhibitors such as the vaccinia virus K3L protein that resembles the N-terminal substrate-targeting domain of eIF2␣. Whereas high-level expression of human PKR was toxic in yeast, this growth inhibition was suppressed by coexpression of the K3L protein.
As part of the mammalian cell innate immune response, the doublestranded RNA activated protein kinase PKR phosphorylates the translation initiation factor eIF2␣ to inhibit protein synthesis and thus block viral replication. Poxviruses including vaccinia and smallpox viruses express PKR inhibitors such as the vaccinia virus K3L protein that resembles the N-terminal substrate-targeting domain of eIF2␣. Whereas high-level expression of human PKR was toxic in yeast, this growth inhibition was suppressed by coexpression of the K3L protein.
We used this yeast assay to screen for PKR mutants that are resistant to K3L inhibition, and we identified 12 mutations mapping to the C-terminal lobe of the PKR kinase domain. The PKR mutations specifically conferred resistance to the K3L protein both in yeast and in vitro. Consistently, the PKR-D486V mutation led to nearly a 15-fold decrease in K3L binding affinity yet did not impair eIF2␣ phosphorylation. Our results support the identification of the eIF2␣-binding site on an extensive face of the C-terminal lobe of the kinase domain, and they indicate that subtle changes to the PKR kinase domain can drastically impact pseudosubstrate inhibition while leaving substrate phosphorylation intact. We propose that these paradoxical effects of the PKR mutations on pseudosubstrate vs. substrate interactions reflect differences between the rigid K3L protein and the plastic nature of eIF2␣ around the Ser-51 phosphorylation site.
eIF2 ͉ translational control T he interplay of viruses and mammalian cells represents an arms race of defense mechanisms and counter measures. Viral infection triggers the innate immune response, including activation of the double-stranded RNA (dsRNA)-activated protein kinase PKR. Consisting of an N-terminal dsRNA-binding domain (dsRBD) and a C-terminal kinase domain (KD), PKR is activated by dsRNA molecules generated during viral replication and gene expression. Once activated, PKR is competent to bind and phosphorylate its substrate, the ␣ subunit of translation initiation factor eIF2 on Ser-51. The eIF2 is a GTP-binding protein that is responsible for binding the MettRNA i
Met to the small ribosomal subunit. Phosphorylation of eIF2␣ converts eIF2 into an inhibitor of its guanine nucleotide exchange factor eIF2B and thereby down-regulates protein synthesis. Because viral protein synthesis depends on the host cell's machinery, PKR inhibition of cellular protein synthesis will block viral mRNA translation as well. To overcome this host defense mechanism, most viruses express inhibitors of PKR.
Among the viral inhibitors of PKR are the adenoviral RNA VA-I and dsRNA-binding proteins such as the vaccinia virus E3L protein, cytomegalovirus TRS-1 and IRS-1 proteins, and reovirus 3 (1-3). Another family of PKR inhibitors includes viral psueudosubstrates. The vaccinia virus K3L protein and the related myxoma virus M156R protein resemble the N-terminal OB-fold domain of eIF2␣ (4, 5) (Fig. 1A) . Although the M156R protein appears to be a PKR substrate, the K3L protein binds to PKR and blocks PKR autophosphorylation and eIF2␣ phosphorylation both in vivo (6) and in vitro (4, 7) . The 88-residue vaccinia virus K3L protein shares 28% amino acid sequence identity to the N terminus of eIF2␣. The structures of the K3L protein and eIF2␣ are strikingly similar, with the greatest differences localized to the helix insert regions (Fig.  1 A) , which includes the Ser-51 phosphorylation site in eIF2␣. The K3L protein directly interacts with the kinase domain of PKR, as revealed by yeast 2-hybrid and in vitro interaction assays (4, (8) (9) (10) (11) . Because the K3L protein and eIF2␣ were found to compete for binding to PKR (11) , it is thought that they bind to the kinase by a common mechanism.
In the structure of the PKR KD bound to eIF2␣, the PKR KD resembles typical protein kinases with a smaller N-terminal lobe involved in ATP binding and a larger C-terminal lobe that mediates substrate interactions (12) . Dimerization of the PKR KD in a back-to-back orientation with dimer contacts restricted to the N-terminal lobe enables each protomer to engage a molecule of eIF2␣. The concave surface of the eIF2␣ OB-fold domain docks on helix ␣G in the C-terminal lobe, and this positions the helix insert region and Ser-51 residue in eIF2␣ in the vicinity of the PKR active site in the cleft between the 2 lobes of the KD (see Fig. 1 A) . Mutational analyses demonstrated that KD dimerization and autophosphorylation on Thr-446 are critical for eIF2␣ phosphorylation and for binding the K3L protein (9) . In addition, mutations that disrupt PKR helix ␣G specifically impair eIF2␣ phosphorylation but not kinase autophosphorylation or phosphorylation of nonspecific substrates (9) . Taken together, the structural and biochemical studies reveal an eIF2␣-binding site on PKR commonly engaged by K3L that extends from helix ␣G to the kinase active site cleft. Given this common binding site, we reasoned that PKR might recognize differences in the helix insert regions to distinguish between its authentic substrate and a pseudosubstrate inhibitor.
Further insights into the molecular mechanism of PKR recognition of eIF2␣ and regulation of the kinase by the K3L protein have been provided by studies in the yeast Saccharomyces cerevisiae. High-level expression of human PKR is toxic in yeast because of phosphorylation of eIF2␣ and the attendant inhibition of translation initiation (13, 14) . Substitution of Ser-51 in eIF2␣ by Ala suppresses PKR toxicity as do mutations that block kinase activity (9, 14, 15) . Coexpression of the vaccinia virus K3L protein or the related swinepox virus C8L protein suppresses PKR toxicity in yeast (16, 17) . Consistent with the notion that the K3L protein is a PKR pseudosubstrate inhibitor, mutations targeting residues in the K3L OB-fold domain that are conserved in eIF2␣ impaired K3L inhibition of PKR both in yeast (17) and in vitro (4) . Moreover, a mutation (H47R) that increased the amino acid sequence identity between K3L and eIF2␣ in the vicinity of the Ser-51 phosphorylation site enhanced K3L inhibition of PKR in yeast (17) .
To gain further insights into how the K3L protein inhibits PKR, and to determine whether PKR can distinguish its substrate eIF2␣ from pseudosubstrate inhibitors, we used a genetic screen to identify PKR mutants that are resistant to inhibition by the K3L protein. Surprisingly, the mutations clustered near helix ␣G, a region thought to interact with K3L and eIF2␣ in a like manner. We propose that subtle alterations to the substrate-binding site on PKR can differentially affect substrate and pseudosubstrate interactions, perhaps reflecting differences in the adaptability of the K3L pseudosubstrate and eIF2␣ to perturbations that alter the spacing between the helix ␣G docking site and the kinase active site cleft.
Results

Screen to Identify PKR Mutants Resistant to Inhibition by the Vaccinia
Virus K3L Protein. Previously, we showed that high-level expression of human PKR under the control of a yeast galactose-inducible promoter was toxic in yeast, and that this toxicity was suppressed by coexpression of the vaccinia virus K3L protein. In addition, we identified the K3L-H47R mutant as a more potent inhibitor of PKR (16, 17) . To facilitate screening for PKR mutants resistant to K3L inhibition, the DNA fragment encoding the galactose-inducible GAL-CYC1 promoter and the K3L-H47R ORF was subcloned to a yeast-integrating vector. We chose to use the robust K3L-H47R mutant for this screen, because it provided a larger window to observe restoration of PKR activity in yeast. The resulting construct and the related empty vector control were directed to integrate at the leu2 locus of a gcn2⌬ strain creating the GAL-CYC1-K3L-H47R strain J674 and the vector control strain J673. As expected, Western blot analyses of extracts from cells grown on galactose medium revealed robust expression of K3L-H47R in J674 but not in J673 (Fig. 1C, bottom) . The expression of human PKR under the control of a galactose-inducible promoter was lethal in strain J673 ( Fig. 1B  Lower) ; however, this toxicity was substantially suppressed in strain J674 that expresses the K3L-H47R protein (Fig. 1B, fifth row) . Consistent with these growth phenotypes, expression of the K3L-H47R protein diminished eIF2␣ phosphorylation on Ser-51 ( We used the K3L-H47R strain to screen for PKR mutants resistant to pseudosubstrate inhibition. The GAL-CYC1-PKR expression vector p1419 was subjected to random mutagenesis by passage through the bacterial mutator strain XL1-red, and the resultant PKR mutant library was introduced into the GAL-CYC1-K3L-H47R strain J674. Transformants were replicaplated to medium containing galactose to induce both K3L-H47R and PKR expression, and colonies that grew slower than controls expressing WT PKR were selected for further analysis. From a screen of Ϸ4,000 yeast transformants, 99 colonies grew slower than the WT control, with 38 of this latter set showing a strong slow-growth phenotype. Sequence analysis of the resistant clones revealed that several of the mutants were isolated more than once, and that 28 contained multiple mutations. Individual point mutations were introduced into the WT PKR expression construct and tested for resistance to K3L inhibition. Finally, 12 single amino acid changes in the PKR kinase domain were identified as conferring resistance to inhibition by K3L-H47R in the yeast assay: E375V, I378T, R382I, I405M, S448G, M455V, A473T, E480D, D486V, T491S, S504L, and E524V [see As shown in Fig. 1B , the representative PKR-D486V mutant strongly inhibited the growth of yeast both lacking and expressing K3L-H47R. Consistently, expression of PKR-D486V led to high levels of eIF2␣ phosphorylation on Ser-51 both in the absence and presence of K3L-H47R coexpression ( The PKR-eIF2␣ complex was generated by substituting the structure of free eIF2␣ (PDB ID code 1Q46), in which the structure of the helix insert region is resolved, in place of eIF2␣ in the PKR-eIF2␣ complex structure (PDB ID code 2A1A). The OB-fold domains of the PKR pseudosubstrate K3L (cyan) and authentic substrate eIF2␣ (red) are aligned and their helix insert regions are colored yellow (K3L) and purple (eIF2␣). PKR N-lobe is colored blue; C-lobe is green; and Ser-51 phosphorylation site in eIF2␣ is denoted by the black circle. (B) Coexpression of K3L-H47R suppresses toxicity associated with expression of PKR, but not PKR-D486V, in yeast. Plasmids expressing PKR or PKR-D486V under the control of the yeast GAL-CYC1 hybrid promoter or the empty vector pRS316 were introduced into the isogenic yeast strains J673 and J674 carrying an integrated LEU2 vector or GAL-CYC1-K3L-H47R construct, respectively. The indicated yeast transformants were grown to saturation, and 5 L of serial dilutions (of OD600 ϭ 1.0, 0.1, 0.01, 0.001, and 0.0001) were spotted on SCGal-Ura medium (synthetic complete medium containing 2% galactose and lacking uracil) and incubated 3 days at 30°C. (C) Immunoblot analysis of PKR and K3L-H47R expression and eIF2␣ phosphorylation. WCEs were prepared from the yeast transformants described in B, as indicated. WCEs were subjected to SDS/PAGE followed by immunoblot analysis using monoclonal antibodies directed against PKR, polyclonal antiserum directed against K3L, or phosphospecific antibodies against Ser-51 in eIF2␣. The eIF2␣ membrane was then stripped and probed using polyclonal antiserum against yeast eIF2␣.
To test whether the PKR mutations relaxed the kinase specificity and conferred toxicity in yeast because of phosphorylation of proteins other than eIF2␣, we expressed the PKR mutants in the strain J82 expressing nonphosphorylatable eIF2␣-S51A. As shown in Fig. 2 A, the toxic affects associated with high-level expression of WT PKR were suppressed in the eIF2␣-S51A strain (compare rows 1 and 2 in the first and third sections). Likewise, the toxic affects of all of the PKR mutants except PKR-S448G were suppressed in the eIF2␣-S51A strain ( Fig. 2 A Right Center, and more apparent in Fig. S1 , row 9). Thus, the majority of the PKR mutants are toxic in yeast expressing K3L-H47R because of enhanced eIF2␣ phosphorylation. Whereas expression of WT PKR is lethal in yeast expressing WT eIF2B, high-level expression of WT PKR causes a slow-growth phenotype in a desensitized yeast strain expressing eIF2B␣-E44D (gcn3-102 mutant allele in strain H17; see Fig. 2 A Left and Right, row 2). If the PKR mutations conferred resistance to K3L-H47R inhibition by hyperactivating the kinase, then these mutants should be more toxic than WT PKR in the eIF2B␣ mutant strain. In contrast, expression of the PKR mutants, except PKR-S448G, conferred the same slow-growth phenotype observed with WT PKR (Fig. 2 A Right, and more apparent in Fig. S1, row 9) . We conclude that the K3L-H47R-resistant PKR mutants are not simply hyperactive kinases. Moreover, the lack of an additional growth defect when expressing the PKR mutants in the eIF2B␣ mutant strain is consistent with the results of Western analyses that showed that the PKR mutants were not overexpressed relative to WT PKR (Fig. S3, and data not shown) . Thus, these results indicate that the mutations restore PKR toxicity in yeast by specifically impairing K3L-H47R inhibition of kinase activity. In contrast, the S448G mutation likely loosens PKR substrate specificity resulting in promiscuous phosphorylation of other proteins and growth inhibition.
To examine the specificity of the PKR mutations in conferring resistance to K3L-H47R vs. other inhibitors, we tested the inhibition of PKR by the vaccinia virus dsRNA-binding E3L protein and by the dominant-negative N-terminal portion of PKR. For these experiments, we focused on the PKR-D486V mutant; however, similar results were obtained for all of the PKR mutants. Coexpression of the vaccinia virus E3L protein or the N-terminal portion of PKR (residues 1-258 containing the dsRNA-binding domain and lacking the kinase domain, PKR-⌬KD) partially suppressed the growth inhibition caused by expression of WT PKR in yeast (Fig.  2B , rows 2, 5, and 8). These PKR inhibitors are thought to block PKR activation through heterodimer formation mediated through the N-terminal dsRNA-binding domains in PKR. Whereas PKR-D486V was resistant to inhibition by the K3L-H47R protein, the toxic affects associated with expression of PKR-D486V in yeast, like WT PKR, was partially suppressed by coexpression of the E3L protein or PKR-⌬KD (Fig. 2B, rows 3, 6, and 9 ). In contrast, PKR-D486V was resistant to inhibition by WT K3L (Fig. S4A) or by the smallpox virus pseudosubstrate C3L protein (Fig. S5) . Thus, we conclude that the PKR mutations specifically confer resistance to pseudosubstrate inhibition by the K3L protein. The crystal structure of eIF2␣ bound to PKR revealed an extensive interface with the OB-fold domain of eIF2␣ docking on helix ␣G in the C-terminal lobe of PKR kinase domain (see Fig. 3A ). Helix ␣G is a notable feature of eIF2␣ kinases in that it is 1 turn longer and 40°tilted from the canonical ␣G observed in all other proteins kinases studied to date (12) . This distinct feature is thought to impart the eIF2␣ protein kinases with the unique ability to bind and phosphorylate eIF2␣ on Ser-51. Aside from helix ␣G the only other notable contact of eIF2␣ to PKR is directed at the P ϩ 1 portion of the kinase domain activation segment. The conformation of the P ϩ 1 loop of protein kinases defines their specificity for Ser/Thr (outward P ϩ 1 orientation) vs. Tyr (inward orientation) hydroxyl groups by providing a platform within the active site that positions the mainchain atoms of the phosphoacceptor site. The P ϩ 1 loop of PKR was notable in adopting a conformation unique from both Ser/Thr and Tyr kinases. This unusual feature likely reflects a unique constraint imposed on the eIF2␣ kinases required for eIF2␣ recognition.
When mapped on the structure of the PKR kinase domain, all 12 K3L-resistant mutations in PKR localized to the C-terminal lobe of the kinase domain (Fig. 3A) . Interestingly, 9 of the 12 mutations cluster to the immediate vicinity of the eIF2␣-binding site at the tip of helix ␣G and to the P ϩ 1 portion of the kinase activation segment (Fig. 3B) . The residues E375, I378 and R382 on helix ␣D, E480 on helix ␣F, D486 on the ␣F-␣G linker and T491 on helix ␣G form a network of interacting residues that supports the eIF2␣ kinase specific orientation of helix ␣G. In contrast, S448 and M455 reside within the kinase domain activation segment and help to define the eIF2␣ specific conformation of the P ϩ 1 loop subelement. Also residing in the P ϩ 1 loop cluster, A473 in helix ␣F forms part of the hydrophobic core that backstops Met-455. Together, the 9 aforementioned mutation sites appear well placed to influence the binding of substrate and pseudosubstrate. Because K3L and eIF2␣ are thought to share a common binding mode to PKR through a similar but not identical complement of interacting residues, these 9 sites of mutation in PKR may differentially affect binding of the 2 proteins by subtly changing local structure. We hypothesize that these 9 mutations perturb binding of the pseudosubstrate (K3L) to a greater extent than the authentic substrate (eIF2␣).
PKR-D486V Mutation Impairs K3L Binding and Confers Resistance to
K3L Inhibition of eIF2␣ Phosphorylation in Vitro. To corroborate our in vivo results, we performed a detailed analysis of PKR mutant function in vitro. Purified WT PKR and PKR-D486V were incubated with recombinant eIF2␣ and [␥-
33 P]ATP and tested for phosphorylation of eIF2␣ using in vitro kinase assays. As shown in Fig. 4A , both WT PKR and PKR-D486V readily phosphorylated eIF2␣. Kinetic analysis of the phosphorylation reactions (Fig. 4A Lower) revealed similar K m values for eIF2␣ phosphorylation by WT PKR (K m ϭ 2.7 M) and PKR-D486V (K m ϭ 3.4 M). Thus, the D486V mutation did not significantly affect the eIF2␣ substrate binding properties of PKR. To study the inhibition of PKR by K3L in vitro, recombinant GST or GST-K3L-H47R fusion protein was added to the in vitro kinase assays. In addition, to specifically examine eIF2␣ phosphorylation on Ser-51, unlabeled ATP was used in the assays and eIF2␣ phosphorylation was monitored by Western blot analysis by using antibodies directed against phospho- 5) or GST-K3L-H47R (lanes 6 -10; 0.5, 1, 2, 4, or 6 M) for 10 min at room temperature, then kinase reactions were initiated by addition of His-tagged eIF2␣ (0.2 M) and 0.2 mM ATP. Reactions were resolved by SDS/PAGE and subjected to immunoblot analysis using phosphospecific antibodies against Ser-51 in eIF2␣ (first and third panel, eIF2␣-P). The membranes were then stripped and probed using polyclonal antiserum against yeast eIF2␣ (second and fourth panel, eIF2␣). (Lower) Relative phosphorylation of eIF2␣ in 3 independent experiments was determined by quantitative densitometry using ImageQuant (Amersham) software. Percentage inhibition was determined by comparing the eIF2␣ phosphorylation results from reactions containing GST-K3L-H47R vs. GST.
Ser-51 on eIF2␣. As shown in Fig. 4B, upper) , addition of GST-K3L-H47R, but not GST, inhibited Ser-51 phosphorylation by WT PKR. In contrast, Ser-51 phosphorylation by the PKR-D486V mutant was not impaired by the addition of GST-K3L-H47R (Fig.  4B , third and fourth sections). As shown in Fig. 4B , lower, addition of GST-K3L-H47R resulted in an Ϸ40% inhibition of eIF2␣ phosphorylation by WT PKR. In contrast, phosphorylation of eIF2␣ by PKR-D486V was insensitive to inhibition by GST-K3L-H47R up to the maximum concentration of inhibitor that could be added in these assays (Fig. 4B, lower) . Consistent with these data, PKR-D486V phosphorylation of eIF2␣ was likewise resistant to inhibition by a WT GST-K3L fusion protein in vitro (Fig. S4B) .
The results of the in vitro kinase assays suggested that the D486V mutation impaired K3L binding to PKR. Because of poor solubility that limited the concentration of K3L that could be added to the in vitro kinase assays, we were unable to measure a K i for K3L inhibition of PKR and PKR-D486V. Instead, we used surface plasmon resonance (SPR) to examine the binding of GST-PKR-KD and GST-PKR-KD-D486V fusion proteins to immobilized WT K3L. The dimeric GST-PKR-KD readily bound to the immobilized K3L (Fig. 5A Upper) with an observed K d of 3.7 M (Fig. 5B) . Under the conditions of this SPR experiment, GST-PKR-KD-D486V displayed minimal binding to the K3L protein (Fig. 5A  Lower) , and the K d for binding was elevated minimally 14-fold (K d ϭ 53.0 M, Fig. 5B ). These results, which are consistent with the lack of inhibition of PKR-D486V by GST-K3L or GST-K3L-H47R in the in vitro kinase assays, indicate that the D486V mutation confers PKR resistance to K3L inhibition by selectively weakening the binding of the pseudosubstrate to the kinase.
Discussion
The structures of K3L and eIF2␣ are strikingly similar, with the only major differences residing in the helix insert region (Fig.  1 A) . The helix insert region in eIF2␣ consists of 2 short 3/10 helices separated by a linker containing the phospho-accepting Ser-51 residue (Fig. 1 A) (18) . Structural analyses of free eIF2␣ indicate that, although the helix insert can adopt a precise ordered conformation, it is likely to be inherently flexible in nature [as reflected by high relative B-factors (18, 19) ]. This is consistent with the observation that the helix insert region of eIF2␣ was dynamically disordered in the PKR-eIF2␣ complex structure (12) . Moreover, in docking the structure of free eIF2␣ onto the PKR-eIF2␣ complex it is apparent that Ser-51 must move Ϸ17 Å to access the PKR active site to accept phosphate. Taken together, these findings indicate that a flexible helix insert region in eIF2␣ is likely to be an important determinant of its ability to be phosphorylated by PKR. In contrast, the helix insert region of K3L is comprised by a 4-turn ␣-helix and a 3/10 helix, which appears to be rigid as indicated by its well-ordered structure with low relative B-factors (4). Inability to undergo conformation change may account in part for why K3L unlike eIF2␣ is not a substrate.
Given that eIF2␣ and K3L share an overlapping binding site on PKR, it was not unexpected that mutations in PKR that affect K3L binding map to the region of PKR extending from helix ␣G to the P ϩ 1 loop in the catalytic cleft. However, because the structural differences between eIF2␣ and K3L are localized to the helix insert region, and this element of eIF2␣ docks into the kinase active site, we reasoned that PKR mutations conferring resistance to K3L (but not affecting eIF2␣ binding) would be biased away from helix ␣G and instead localize more toward the catalytic cleft (the P ϩ 1 loop for example). Indeed, we showed that mutation of Thr-487 at the tip of helix ␣G blocked eIF2␣ phosphorylation (9) . Therefore, we were surprised that the majority of the K3L-resistant mutations in PKR clustered near helix ␣G.
So why is it that we identified so many mutations in and around helix ␣G that confer resistance to K3L and so few mutations in the vicinity of the kinase active site? One possibility is that mutations in the kinase active site region that perturb K3L binding have a greater probability of perturbing protein kinase catalytic function. Because the yeast genetic screen demanded both impaired K3L inhibition and robust eIF2␣ kinase activity, mutations in the active site might have been excluded because of negative effects on eIF2␣ phosphorylation. This counterselection against active-site mutations limited mutations to the helix ␣G region of PKR, the only other region that makes prominent contacts with substrate or pseudosubstrate.
So how do mutations in the helix ␣G region of PKR confer resistance to K3L inhibition? Because the toxic phenotypes of the PKR mutants (other than S448G) were suppressed in the eIF2␣-S51A strain (Fig. 2 A) , the PKR mutations did not confer toxicity in yeast through broadened substrate recognition properties and promiscuous phosphorylation of heterologous substrates. Likewise, because the mutant forms of PKR were not more toxic than WT PKR in the eIF2B␣ mutant strain (Fig. 2 A) , and WT PKR and PKR-D486V phosphorylated eIF2␣ with similar kinetic properties (K m and V max , Fig. 4A ), the PKR mutations do not hyperactivate the kinase. In contrast, SPR experiments showed that the D486V mutation decreased PKR affinity for K3L by Ϸ14-fold (Fig. 5) , indicating that the mutations specifically weakened pseudosubstrate binding to PKR.
We propose that differences in the relative flexibility of K3L and eIF2␣ account for the apparent specificity of the PKR helix ␣G mutations. The OB-fold domain of the rigid K3L protein docks on PKR helix ␣G, and its helix insert region likely contacts the active-site cleft to form a stable complex. Contacts with both helix ␣G and the active-site cleft contribute to K3L affinity for PKR, as evidenced by the fact that mutations on the surface of the K3L OB-fold domain (Y76K) and in the helix insert (V44Q) dramatically impair the ability of K3L to bind to and inhibit PKR catalytic activity (4) . Like K3L, the eIF2␣ OB-fold domain docks on PKR helix ␣G positioning the helix insert region near the active site. However, in contrast to K3L, the helix insert region of eIF2␣ undergoes a conformational change to position the Ser-51 residue at the phospho-acceptor site in the kinase (12) . Thus, we propose the flexible helix insert in eIF2␣ distinguishes the PKR substrate from its pseudosubstrate with a rigid helix insert. Interestingly, the identified hyperactive K3L-F36S mutant (17) readily suppressed PKR and PKR-D486V toxicity in yeast (Fig. S4A) , and recombinant GST-K3L-F36S inhibited eIF2␣ phosphorylation in vitro by both PKR and PKR-D486V (Fig. S4B) . Although remote from the region of K3L that contacts PKR, the F36S mutation is located near the beginning of strand ␤3 that precedes the helix insert region. Perhaps the F36S mutation alters the spacing between the OB-fold and helix insert region such that K3L can inhibit both WT PKR and the PKR-D486V mutant.
It is interesting that most of the PKR mutations conferring resistance to K3L do not lie at points of contact between PKR and eIF2␣, rather the mutations appear to be slightly removed from the contact points. We propose that these mutations slightly alter the position of the eIF2␣/K3L contact sites. For example, the mutations in helix ␣F, which lies behind and buttresses helix ␣G, are likely to alter the position of helix ␣G. Slightly moving helix ␣G may significantly impair binding of K3L, because the helix insert region will no longer properly contact the PKR active site. In contrast, slight repositioning of helix ␣G may not affect eIF2␣ phosphorylation, because the flexible helix insert region can compensate for the altered docking and still insert the Ser-51 residue into the kinase active site. Further insights into the mechanism of action of the PKR suppressor mutations and the structural differences underlying the alternate functions of K3L and eIF2␣ await structural analysis of a PKR-K3L complex, and comparison with the existing complex between PKR and eIF2␣.
Materials and Methods
Yeast Strains. Strains H17 (MAT␣ gcn3-102 leu2-3 leu2-112 ura3-52) (20) Experimental Conditions. Immunoblot analyses of protein expression and eIF2␣ phosphorylation in yeast were performed as described in ref. 9 . Yeast transformants were grown in SD medium to log phase and then transferred to SGal medium (2% galactose) for 12-16 h to induce PKR and K3L expression. Whole-cell extracts (WCEs) (Ϸ2-5 g) were resolved by SDS/PAGE and subjected to immunoblot analysis using antibodies specific for phospho-Ser-51 on eIF2␣ (BioSource International), polyclonal antiyeast eIF2␣ antiserum, monoclonal antibodies against an N-terminal epitope in human PKR (lot71/10, Ribogene), or polyclonal K3L antiserum. Additional methods are provided in SI Text.
